Active ingredient
- risdiplam
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 00031/0920.
Evrysdi 0.75 mg/mL powder for oral solution
Package leaflet: Information for the patient
Evrysdi 0.75 mg/mL powder for oral solution
risdiplam
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
Read all of this leaflet carefully before you or your child start taking this medicine because it contains important information for you.
What is in this leaflet
1. What Evrysdi is and what it is used for
2. What you need to know before you or your child take Evrysdi
3. How to take Evrysdi
4. Possible side effects
5. How to store Evrysdi
6. Contents of the pack and other information
1. What Evrysdi is and what it is used for
What Evrysdi is
Evrysdi is a medicine that contains the active substance risdiplam.
What is Evrysdi used for
Evrysdi is used to treat spinal muscular atrophy (SMA), a genetic disease. It can be used in patients from 2 months of age.
What spinal muscular atrophy is
SMA is caused by a shortage of a protein called survival motor neuron (SMN) protein in the body. Lack of SMN protein can cause you or your child to lose motor neurons, which are nerve cells that control muscles. This leads to muscle weakness and wasting that can affect everyday movements such as head and neck control, sitting, crawling and walking. The muscles used for breathing and swallowing may also become weaker.
How Evrysdi works
Risdiplam, the active substance in Evrysdi, works by helping the body produce more SMN protein. This means fewer motor neurons are lost, which may improve how well muscles work in people with SMA.
In infants with SMA Type 1 treated in clinical trials for 1 year, Evrysdi has helped to:
In children (toddlers to adolescents) and adults with SMA Type 2 and 3, Evrysdi may maintain or improve muscle control.
2. What you need to know before you or your child take Evrysdi
Do not take Evrysdi:
If you are not sure, talk to your doctor or pharmacist before you or your child take Evrysdi.
Warnings and precautions
Talk to your doctor, nurse or pharmacist before you or your child take Evrysdi.
Treatment with Evrysdi may harm your unborn baby or may affect male fertility. See “Pregnancy, contraception, breast-feeding and male fertility” for more information.
Other medicines and Evrysdi
Tell your doctor or pharmacist if you or your child are taking, have recently taken or might take any other medicines in the future.
In particular tell your doctor, pharmacist or nurse if you are taking or have received in the past any of the following medicines:
Pregnancy, contraception, breast-feeding and male fertility
Pregnancy
You and your doctor will decide what is best for you and your unborn baby.
Contraception
For women
Do not become pregnant:
Talk to your doctor about reliable methods of birth control that you and your partner should use during treatment and for one month after you stop treatment.
For men
If your female partner is of childbearing potential, you need to avoid pregnancy. Use condoms during your treatment with Evrysdi and continue to use condoms 4 months after treatment has finished.
Breast-feeding
Do not breast-feed while taking this medicine. This is because Evrysdi may pass into breast milk and may, therefore, harm your baby.
Discuss with your doctor if you should stop breast-feeding or if you should stop taking Evrysdi.
Male fertility
Based on findings in animals, Evrysdi may reduce male fertility while on treatment and for up to 4 months after your last dose. If you are planning to have a child, ask your doctor for advice.
Do not donate sperm during your treatment and for 4 months after your last dose of Evrysdi.
Driving and using machines
Evrysdi is unlikely to affect your ability to drive and use machines.
Evrysdi contains sodium
Evrysdi contains a small amount of sodium (salt) - there is less than 1 mmol (23 mg) sodium even at the highest daily dose of 5 mg (6.6 mL of 0.75 mg/mL oral solution). This means it is essentially ‘sodium-free’ and can be used by people on a sodium-restricted diet.
Evrysdi contains 0.375 mg of sodium benzoate per mL. Sodium benzoate may increase jaundice (yellowing of the skin and eyes) in newborn babies (up to 4 weeks old).
Evrysdi contains isomalt
Evrysdi contains 2.97 mg of isomalt per mL. If you have been told by your doctor that you or your child have an intolerance to some sugars, contact your doctor before taking this medicinal product.
3. How to take Evrysdi
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. You should receive Evrysdi as a liquid in a bottle. Do not use if the medicine in the bottle is a powder, and contact your pharmacist.
You must also carefully read and follow the enclosed “Instructions for use” booklet on how to take or give Evrysdi.
How much Evrysdi to take
You or your child must take your daily dose as instructed by your doctor. Do not change the dose without speaking with your doctor.
When and how to take Evrysdi
Read the ‘Instructions for use’ booklet
A booklet with ‘Instructions for use’ is included in the pack. It shows you how to withdraw your dose using the re-usable oral syringe given to you. You (or your child) can take the medicine:
How long to take Evrysdi for
Your doctor will tell you how long you or your child need to take Evrysdi for. Do not stop treatment with Evrysdi unless your doctor tells you to.
If you or your child take more Evrysdi than you should
If you or your child take more Evrysdi than you should, talk to a doctor or go to hospital straight away. Take the medicine pack and this leaflet with you.
If you or your child forget to take Evrysdi or vomits after a dose
If you spill Evrysdi
If you spill Evrysdi, dry the area with a dry paper towel and then clean the area with soap and water. Throw away the paper towel in the waste and wash your hands well with soap and water.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
The following side effect has been reported since the marketing of Evrysdi but the frequency for it to occur is not known:
Reporting of side effects
If you or your child get any side effects, talk to your doctor or pharmacist or nurse.This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store
5. How to store Evrysdi
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Evrysdi contains
What Evrysdi looks like and contents of the pack
Marketing Authorisation Holder and Manufacturer
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in January 2022
Instructions for Use – Administration
Evrysdi 0.75 mg/mL powder for oral solution
risdiplam
Be sure to read and understand the Instructions for Use before you start using Evrysdi. These instructions show you how to prepare and give Evrysdi through an oral syringe, gastrostomy tube (G-tube), or nasogastric tube (NG-tube).
If you have any questions about how to use Evrysdi, speak with your doctor or pharmacist.
Evrysdi should come as a liquid in a bottle when you receive it. Evrysdi is prepared by a pharmacist into an oral solution. Do not use if the medicine in the bottle is a powder and contact your pharmacist.
Important information about Evrysdi
Each EVRYSDI carton contains (See figure A):
1. 1 Evrysdi bottle with bottle adapter and cap
2. 2 Oral syringes 6 mL (in pouches)
3. 2 Oral syringes 12 mL (in pouches)
4. 1 Instructions for Use booklet (not shown)
5. 1 Package Leaflet (not shown)
How to store Evrysdi
Please see section 5 “How to store Evrysdi” of the Package Leaflet for full information.
A) Withdrawing your dose volume
How to select the correct oral syringe for your dose of Evrysdi
How to withdraw your dose of Evrysdi
Step A1
Remove the cap by pushing it down and then twisting it to the left (counter-clockwise) (See Figure B). Do not throw away the cap.
Step A2
Push the plunger of the oral syringe all the way down to remove any air in the oral syringe (See Figure C).
Step A3
Keeping the bottle upright, insert the syringe tip into the bottle adapter (See Figure D).
Step A4
Carefully turn the bottle upside down with the syringe tip firmly inserted into the bottle adapter (See Figure E).
Step A5
Slowly pull back on the plunger to withdraw your dose of Evrysdi. The top of the black plunger stopper must line up with the mL marking on the oral syringe for your daily dose (See Figure F).
After you have drawn up the correct dose, hold the plunger in place to keep it from moving.
Step A6
Continue to hold the plunger in place to stop it moving. Leave the oral syringe in the bottle adapter and turn the bottle to an upright position. Place the bottle onto a flat surface. Remove the oral syringe from the bottle adapter by gently pulling straight up on the oral syringe (See Figure G).
Step A7
Hold the oral syringe with the syringe tip pointing up. Check the medicine in the oral syringe. If there are large air bubbles in the oral syringe (See Figure H) or if you have drawn up the wrong dose of Evrysdi, insert the syringe tip firmly into the bottle adapter. Push the plunger all the way down so that the medicine flows back into the bottle and repeat Steps A4 to A7.
Take or give Evrysdi immediately after it is drawn up into the oral syringe.
If it is not taken within 5 minutes, discard the medicine from oral syringe and withdraw a new dose.
Step A8
Put the cap back on the bottle. Turn the cap to the right (clockwise) to tightly close the bottle (See Figure I). Do not remove the bottle adapter from the bottle.
If you are taking your dose of Evrysdi by mouth, follow the instructions in “B) How to take a dose of Evrysdi by mouth”.
If you are taking your dose of Evrysdi through a gastrostomy tube, follow the instructions in “C) How to give a dose of Evrysdi through a gastrostomy tube (G-tube)”.
If you are taking your dose of Evrysdi through a nasogastric tube, follow the instructions in “D) How to give a dose of Evrysdi through a nasogastric tube (NG-tube)”.
Evrysdi’s oral syringes are specifically designed to be compatible with the ENFit® system. If your feeding tube is not ENFit® compatible, you may need an ENFit transition connector to connect the Evrysdi syringe to your G-tube or NG-tube.
B) How to take a dose of Evrysdi by mouth
Sit upright when taking a dose volume of Evrysdi by mouth.
Step B1
Place the oral syringe into the mouth with the tip along either cheek.
Slowly push the plunger all the way down to give the full dose of Evrysdi (See Figure J).
Giving Evrysdi into the back of the throat or too fast may cause choking.
Step B2
Check that there is no medicine left in the oral syringe (See Figure K).
Step B3
Drink some water right after taking the dose of Evrysdi (See Figure L).
Go to Step E for cleaning of the syringe.
C) How to give a dose of Evrysdi through a gastrostomy tube
If you are giving Evrysdi through a gastrostomy tube, ask your doctor or nurse to show you how to inspect the gastrostomy tube before giving Evrysdi.
Step C1
Place the oral syringe tip into the gastrostomy tube. Slowly push the plunger all the way down to give the full dose of Evrysdi (See Figure M).
Step C2
Check that there is no medicine left in the oral syringe (See Figure N).
Step C3
Flush the gastrostomy tube with 10-20 mL of water right after giving the dose of Evrysdi (See Figure O).
Go to Step E for cleaning of the syringe.
D) How to give a dose of Evrysdi through a nasogastric tube
If you are giving Evrysdi through a nasogastric tube, ask your doctor or nurse to show you how to inspect the nasogastric tube before giving Evrysdi.
Step D1
Place the oral syringe tip into the nasogastric tube. Slowly press the plunger all the way down to give the full dose of Evrysdi (See Figure P).
Step D2
Check that there is no medicine left in the oral syringe (See Figure Q).
Step D3
Flush the nasogastric tube with 10-20 mL of water right after giving the dose of Evrysdi (See Figure R).
Go to Step E for cleaning of the syringe.
E) How to clean the oral syringe after use
Step E1
Remove the plunger from the oral syringe.
Rinse the oral syringe barrel well under clean water (See Figure S).
Step E2
Rinse the plunger well under clean water (See Figure T).
Step E3
Check that the oral syringe barrel and plunger are clean.
Place the oral syringe barrel and plunger on a clean surface in a safe place to dry (See Figure U).
Wash your hands.
Once dry, reassemble the plunger into the oral syringe barrel and store the syringe with your medicine.
gb-pl-evrysdi-clean-220202-0.75mg-pos
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
+44 (0)1707 366 000
+44 (0)800 328 1629
+44 (0)800 731 5711
+44 (0)1707 338 297
+44 (0)1707 384555